They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...

The decision to limit Mounjaro injections to 220,000 people is ‘short-sighted and absurd’, says the former prime minister’s ...

Despite an estimated 3.4 million people in England meeting the eligibility criteria for Mounjaro, fewer than 10% will ...

With obesity rates skyrocketing in the UK, the a 28-year-old social media specialist expressed support for the wider ...

Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period.

Weight-loss drug Mounjaro is set to be rolled out on the NHS in England from March. It is one of many weight-loss drugs that have become increasingly popular in recent years, and are sold ...

The NHS could start administering a new weight-loss injection as early as March 2025, but eligible patients may have to wait more than a decade to receive it. The Mounjaro jab has been branded the ...

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone ...